SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,810.00    115.00 (1.72%)
Bid:
6,770.00
Ask:
6,775.00
Spread: 5.00 (0.074%)
Market Cap: £5.03b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

8 Nov 2010 07:00

RNS Number : 7397V
Spirax-Sarco Engineering PLC
08 November 2010
 



 

Spirax-Sarco Engineering plc

 

Charlton House

Cheltenham

Glos. GL53 8ER

 

 

News Release

 

 

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

 

 

Monday 8th November 2010

INTERIM MANAGEMENT STATEMENT

 

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the period since 30th June 2010.

 

Trading

Sales growth thus far in the second half has improved from the first half year. Sales for the ten months through October 2010 were ahead 14%, including an organic sales increase of 9%, with 5% contributed equally between acquisitions and favourable currency movements. Sterling has been relatively stable over recent months and at current exchange rates, we would expect to see a similar percentage currency gain for the full year.

Since the half year, sales in the steam business increased strongly in Asia Pacific as several large projects were shipped in Korea. In the Americas, organic sales growth was in line with the first half due to a stronger performance in South America offset by some weakening in North America. Following a flat first half year, we saw moderate sales growth in EMEA led by strong performances from Germany and Russia. Watson-Marlow, our peristaltic pump business, continued its robust sales growth.

 

Adjusted operating profit continues to benefit from good operational gearing, the cost reductions implemented last year and favourable currency movements. In the period, we continued to invest in our global manufacturing strategy, add sales resources in developing markets and increase R&D investments, all aimed at enhancing our future growth and margin prospects.

 

Financial position

We operate with a strong balance sheet and the Group had a net cash balance of £30 million at 31st October 2010. There has been no material change in the financial position of the Group during the period.

 

Outlook

Global economic activity and industrial output have shown positive growth this year, although more recently the rates of growth have been broadly slowing and we remain alert to any significant slowdown. Sales growth returned in the last two months of 2009 and the easier comparisons are therefore now behind us. However, we expect to make good progress in 2010 and, as we reported at the half-year, to see a more normal second-half bias of sales and profits.

 

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs over 4,500 people, of whom over 1,200 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLBDBCSGBGGU
Date   Source Headline
1st Mar 20227:30 amRNSChange of Director Details
31st Jan 20227:00 amRNSCompletion of the acquisition of Cotopaxi
24th Jan 20227:00 amRNSAcquisition to accelerate digital strategy
17th Nov 20217:00 amRNSTrading Update
15th Nov 20211:54 pmRNSDirector/PDMR Shareholding
11th Aug 20214:46 pmRNSCorrection to Dividend Record Date in News Release
11th Aug 20217:00 amRNS2021 Half Year Results
3rd Aug 20217:00 amRNSBoard Changes
22nd Jun 20217:00 amRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSNew Sustainability Targets Launched
4th Jun 20218:12 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSNews Release - Investor Seminar
12th May 20214:53 pmRNSResult of AGM
12th May 20217:00 amRNSAGM TRADING UPDATE
10th May 20219:16 amRNSDirector/PDMR Shareholding
12th Apr 202111:44 amRNSDirector/PDMR Shareholding
26th Mar 20218:12 amRNSDirector/PDMR Shareholding
10th Mar 20217:00 amRNS2020 Preliminary Results
9th Mar 20218:30 amRNSBoard Appointment
7th Jan 20214:05 pmRNSDirector/PDMR Shareholding
14th Dec 202010:00 amRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSTrading Update
9th Nov 20209:00 amRNSBoard Appointments
21st Oct 20209:21 amRNSChange of Director Details
12th Oct 20205:08 pmRNSDirector/PDMR Shareholding
12th Oct 202010:00 amRNSDirectorate Change
14th Sep 20208:00 amRNSChief Financial Officer
18th Aug 20204:19 pmRNSDirector/PDMR Shareholding
12th Aug 20207:00 amRNS2020 Half Year Results
6th Aug 20208:00 amRNSAdditional Listing
28th Jul 202012:24 pmRNSSection 430(2b) Companies Act - Nimesh Patel
23rd Jul 20207:30 amRNSChange of Director Details
22nd Jun 20203:39 pmRNSChange of Director Details
22nd Jun 20202:45 pmRNSDirector/PDMR Shareholding
20th May 20209:00 amRNSChange of Director Details
13th May 20204:32 pmRNSResult of AGM
13th May 20207:00 amRNSAGM Statement - Trading Update
28th Apr 202011:30 amRNSDisclosure of Rights attached to Equity Shares
24th Apr 20208:59 amRNSAGM Alternative Arrangements
8th Apr 202010:33 amRNSSection 430(2B) Companies Act 2006 Statement
3rd Apr 202011:14 amRNSDirector/PDMR Shareholding
2nd Apr 20208:00 amRNSSpirax Sarco appoints next Chief Financial Officer
30th Mar 20208:30 amRNSChange of Director Details
13th Mar 20209:48 amRNSDirector/PDMR Shareholding
12th Mar 202012:00 pmRNSDirector/PDMR Shareholding
11th Mar 20207:05 amRNSBoard Change
11th Mar 20207:00 amRNS2019 Preliminary Results
7th Feb 20205:35 pmRNSDirector Declaration
13th Nov 20197:00 amRNSTrading Update
10th Sep 20193:30 pmRNSChange of Director Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.